Note: Descriptions are shown in the official language in which they were submitted.
W O 92/07056 PC~r~US91/07742
-1- 2~7200~
~ET~OD AND COMPOSITION FOR C~EANING CONTACT LENS~fi
BACKGROUND OF THE INV~.NllON
Field of the Invention
This invention relates generally to a method and
composition for cle~ni ng contact lenses. In one as-
pect, the present invention relates to a method and
composition for cleaning contact lenses with cyclodex-
trins while in another aspect it relates to a method
for simultaneously cle~n;ns and disinfecting contact
lenses by contacting the lenses with compositions con-
taining cyclodextrins either under elevated tempera-
tures or in the presence of antimicrobial agents.
Description of Art
In the normal course of wearing contact lense~,
tear film and debris consisting of proteinaceous, oily,sebaceous, and related organic matter have a tenAency
to deposit and build-up on lens surfaces. As part of
the routine and proper care regimen, contact lenses
must be cleaned to remove these tear film deposits and
debris. If these deposits are not properly removed,
both the wettability and optical clarity of the lenses
are substantially reduced causing discomfort for the
wearer.
Conventionally, the cl An;ng of contact lenses is
accomplished with one or both of two general classes of
cleaners. Surfactant cleaners, generally known as
"daily cleaners" because of their rec- ~nded daily
use, are effective for the 1~ -vdl of most carbohydrate
and lipid derived matter. However, they are not as
effective for the removal of proteinaceous matter such
W092/070~ PCT/US91/07742
-2- %~72~
as lysozyme. Proteolytic enzymes derived from plant,
animal, and microbial sources are generally used to
remove the proteinaceous deposits. These "enzyme"
cleaners are typically recommended for weekly use and
are conventionally employed by dissolving enzyme-
containing tablets in suitable solutions. Both
cleaners are currently re~ ?nded for proper care of
contact lenses, particularly those made from
hydrophilic materials.
Cyclodextrins have been known for nearly a century
being first isolated from the degradation products of
starch. They are cyclic oligosaccharides produced by
the enzymatic degradation of starch. The degradation
enzymes used are typically produced by various
microorg~ni~ ~ such as bacilli. Generally,
cyclodextrins have been commercially employed in the
pharmaceutical industry as inclusion or entrapment
agents for the purpose of solubilizing relatively
insoluble compounds, preventing the evaporation of
volatile compounds, stabilizing volatile or heat labile
compounds, enh~ncing the bioavailability of certain
drugs and related p~r~oses. Hence, conventional uses
of cyclodextrins involve the inclusion of an active
compound into the cyclodextrin molecular structure
prior to use and employ the cyclodextrin as a means for
delivering the active compound.
It has now been found that cyclodextrin composi-
tions can be employed under ambient and elevated tem-
peratures to remove many of the deposits, which adhere
to contact lenses during normal wear including, pro-
teinaceous matter, typically the most difficult de-
posits to remove. These compositions contain
cyclodextrins which do not contain active c_ pounds
incorporated into the cavity of the cyclodextrin.
W092/070~ rCT/US91/07742
~3~ 2~
Moreover, it has been surprisingly found that the
continued and regular use of cyclodextrin cleAning
compositions result in an effective technique for
preventing proteinaceous deposit build-up on contact
lenses.
SUMMARY OF THE lNv~llON
According to this invention, a method for cl~n;ng
contact lenses is provided comprising contacting the
lenses with a composition containing from 0.0001% to
about 10~ by weight of one or more cyclodextrins for a
time sufficient to clean the lenses. A contact lens
cleaning composition is also provided comprising from
0.0001% to about 10% by weight of one or more
cyclodextrins.
Also provided herein is a method for simultane-
ously cleaning and disinfecting contact lenses
comprising contacting the lenses with a composition
contAin;n~ from 0.0001% to about 10% by weight of one
or more cyclodextrins at a temperature of at least
about 60~C for a time sufficient to clean and disinfect
the lenses.
Yet another method is provided herein for
simultaneously cl~Aning and disinfecting contact lenses
comprising contacting the lenses with a c ,osition
contAining from 0.0001% to about 10% by wei~ht of one
or more cyclodextrins and a disinfecting amount of an
antimicrobial agent for a time sufficient to clean and
disinfect the lenses.
WO 92/07056 PCl'/us9l/~7742
~72~
DETAILED DESCRIPTION OF THE lNv~:NlloN
The present invention can be used with all contact
lenses such as conventional hard, soft, rigid gas per-
meable, and silicone lenses but is preferably employedwith soft lenses such as those commonly referred to as
hydrogel lenses prepared from monomers such as hydrox-
yethylmethacrylate, vinylpyrrolidone, glycerol-
methacrylate, methacrylic acid or acid esters and the
like. Hydrogel lenses typically absorb significant
amounts of water such as from 4 to 80 percent by
weight.
The compositions employed herein contain at least
one or more cyclodextrins in a suitable carrier. Other
active or inactive components can also be employed in
the cleaning compositions.
As described above, the cyclodextrins used in the
present invention are cyclic oligosaccharides produced
by the enzymatic degradation of starch and have multi-
ple glucose or glucopyranose units, usually 6 to 8
units. Depen~i ng on the particular preparation reac-
tion conditions employed, cyclodextrins generally con-
tain six, seven or eight of such units, connected byalpha-(1,4) bonds. The six, seven or eight unit cy-
clodextrins are commonly known as alpha-, beta-, and
gamma-cyclodextrins, respectively.
Cyclodextrins have the shape of truncated cones
with primary and secondary hydroxyl groups located at
opposite ends of the torus. The glucosyl-o-~ridges
point into the center of the molecule and the primary
hydrogel groups project from one outer edge while the
secondary hydroxyl groups project from the other edge.
The result is a molecule with a relatively hydropho~ic
W092/070~ PCT/US91/07742
~5~ 2372~
center and a hydrophilic outer surface. These shapes
and hydrophilic/hydrophobic domains provide for inclu-
sion or incorporation of guest molecules into the cen-
ter of the molecule.
Cyclodextrins are well known and are commercially
produced by the enzymatic degradation of starch. For
example, beta-cyclodextrin is the major product of the
reaction between the enzyme cyclodextrin transglycosy-
lase and a starch solution pretreated with gamma-amy-
lase.
As used herein, the term "cyclodextrins" includes
all cyclodextrin derivatives, such as cyclodextrin
carbonates, ethers, esters, and polyethers; polymers or
copolymers of polymerized cyclodextrins, such as poly-
merized beta-cyclodextrins; and substituted cyclodex-
trins such as those with functional groups bonded to
one or more of the hydroxyl groups. Suitable function
groups include, but are not limited to, methyl, ethyl,
hydroxyethyl, and hydroxypropyl and acetyl yL UU~S .
The pre~erred cyclodextrins are the beta-
cyclodextrins and most preferred are beta-cyclodextrin
selected from beta-cyclodextrin, hydroxypropyl beta-
cyclodextrin, methyl beta-cyclodextrin and hydroxyethyl
beta-cyclodextrin when the cyclodextrin compositions
are employed at elevated temperatures.
The present invention employs an effective amount
of cyclodextrin to clean the lenses. An effective
A -- I L is that required to remove a substantial portion
of the proteinaceous deposits, which occur during nor-
mal wear of contact lenses, in a reasonable time. The
precise amount of cyclodextrin required to make an ef-
fective cleaner will depend on several factors includ-
W O 92/070~6 PC~r/US91/07742
-6- ~7~
ing the type of cyclodextrin, the amount of proteina-
ceous matter deposited on the lenses, the desired
soaking period, the specific type of materials
comprising the lenses, and the like. Further, it
should be appreciated by one skilled in the art, that
the cyclodextrin concentrations useful herein will be
adjusted depending upon the time allowed for removing
the proteinaceous matter, the other components in the
composition and the factors previously mentioned.
However, cyclodextrins will generally be present in an
amount from 0.0001% to about 10% by weight with from
about 0.01% to about 2.0% being preferred.
The compositions of the present invention may
contain various additional components which do not ad-
versely affect, to any significant extent, the activity
of the cyclodextrins. Illustrative examples of ~c ~
nents which may be found in the composition include one
or more of a suitable antimicrobial agent, buffering
agent, chelating and/or seguestering agent, a tonicity
ad~usting agent, and surfactant.
The cyclodextrin composition may contain a pre-
serving or disinfecting -u~,t of one or more antimi-
crobial agents which are compatible with and do notadversely affect the activity of the cyclodextrins or
other components. Suitable chemical antimicrobial
agents, as the term is used herein, include quaternary
~ -rium salts and polymers used in ophthalmic
applications such as poly[(dimethyliminio)-2-butene-
1,4-diyl chloride], t4-tris(2-hydroxyethyl) ammonio~-2-
butenyl-W-ttris(2-hydroxyethyl) ammonio~dichloride
(chemical registry ~ her 75345-27-6) generally
available as polyquaternium 1~ from ONYX Corporation;
benzalkonium halides: trialkylammonium halides;
biguanides such as salts of alexidine, alexidine free
WOg2/070~ PCT/US91/07742
-7-
~72~
base, salts of chlorhexidine, hexamethylene biguanides
and their polymers; and the like. The salts of
alexidine and chlorhexidine can be either organic or
inorganic and are typically gluconates, nitrates,
acetates, phosphates, sulfates, halides and the like.
Suitable oxidative antimicrobial agents, as the
term is used herein, include any peroxide sources which
produce active oxygen in solution and any iodine
liberating sources which produce preserving or
disinfecting ~ -UJI~S of iodine compounds in solution.
Examples of such agents include hydrogen peroxide and
its alkali metal salts; al~ali metal perborates and
persulfates; alkali metal carbonate peroxide:
diperisophthalic acid; peroxydiphosphate salts; ~odium
aluminium aminohydroperoxide; iodine and iodophors.
Preferred oxidative antimicrobial agents are peroxides
and iodophors.
The antimicrobial agents can also be employed af-
ter the cleaning step using the cyclodextrin composi-
tion. In this application, the cleaning step would be
followed with a disinfecting step in a conventional
regimen.
A preserving amount of an antimicrobial agent is
an ; unl which will substantially inhibit the
microorganism population from growing while a
disinfecting amount is an amount which will reduce the
microorganism population. Preferably, a preserving
amount of antimicrobial agent will substantially
inhibit the microorganism population growth for at
least thirty (30) days after exposure to environmental
air. Preferably, a disinfecting - ullL of an anti-
microbial agent is that which will reduce the microbialburden by about two log orders in four hours and, more
WOg2/070~ PCT/U~9t/07742
-8- 2072~
preferably, by about one log order in one hour.
Typically, such agents are present in concentrations
ranging from about 0.00001% to about 0.5% (w/v), and
more preferably, from about 0.00003~ to about 0.05%
(w/v).
The compositions of the present invention can be
prepared in various physical forms such as liquids,
solids, emulsions or colloidal suspensions. For exam-
ple, the cyclodextrins and additional ingredients canbe dissolved or suspended in a suitable solvent such as
water, glycerol, propylene glycol and the like.
Alternatively, the _ osition can be in the form of a
powder or tablet wherein the latter will typically
contain binders or other excipients commonly used in
the tableting industry. Further, the cyclodextrins can
be incorporated into liposomes, microsponges,
microspheres and other drug delivery systems.
Rather than including a disinfecting amount of an
antimicrobial agent into the present composition, the
cleaning composition can also be formulated for use in
a contact lens heat disinfecting apparatus. Such de-
vices are well known and are c~ ?rcially available
through numerous companies. These devices typically
raise the temperature of the composition inside their
wells to between about 60-C and lOO-C for about 20 to
60 minutes as required to disinfect the lenses.
During the normal practice of one embo~ -nt of
the present invention, soiled lenses are placed in the
cleAning composition for a period of about 15 minutes
to about 12 hours either with or without a prior rub-
bing (as is currently res_ -n~ed for daily cleaners).
After soAk;ng the lenses for the appropriate time, the
lenses are removed and disinfected using conventional
W092/07056 PCT~ 7~
_g_
techniques such as elevated temperatures or disinfect-
ing solutions.
In another embodiment of the invention, the
composition can contain an effective amount of an
antimicrobial agent. The composition can then be
employed to simultaneously clean and disinfect the
lenses during the required so~ki ng period. In the case
of oxidative antimicrobial agents, the residual agent
remaining on the lenses must be neutralized prior to
placing the lenses in the eye. Such neutralizing
agents and methods are well known in the art. In the
case of chemical antimicrobial agents, a neutralization
step is generally not required.
In a preferred embodiment of the invention, the
cle~ning composition is placed in a contact lenses heat
disinfecting unit which is capable of raising the tem-
perature of the composition to at least 60-C for at
least about 10 minutes or as otherwise necess~ry to
disinfect the lenses. The soiled contact lenses are
then placed in the cleaning c_ ,osition within the unit
for a time sufficient to clean and disinfect the
lenses. ~ypically, the cle~n;ng and disinfecting pro-
cess will take less than about 60 minu~es depPn~in~ onthe specific unit employed and is typically about 15 to
about 40 minutes. Conventional heat disinfecting units
already known to disinfect contact lenses are suitable
for use with the cyclodextrin co ~sition to achieve
30 cle~ning and disinfection. Advantageously, the lenses
can be re~oved from the solution and placed directly
into the ~ye without the neec for a separate
disinfecting or neutralizing step. Optionally, the
lenses may be rinsed with a suitable isotonic aqueous
solution prior to insertion into the eye.
W092t070~ PCT/USgl/07742
-lO- 2072~
The following detailed examples are presented to
illustrate the present invention. Both ambient and
thermal (elevated temperatures) cle~n;ng efficacy were
performed using protein deposited Group IV contact
lenses and cyclodextrin compositions. All percentages
below are by weight.
Group IV (etafilcon 58% water) lenses were de-
posited by soaking each lens for 18 hours at 37-C
19 (approximate corneal ~emperature). The soaking solu-
tion consisted of four major tear proteins: lysozyme,
albumin, lactoferrin, and mucin; and electrolytes, all
in concentrations reportedly found in human tears. The
final soaking solution contained 0.1% mucin, 0.17
lysozyme, 0.05~ lactoferrin, 0.085% albumin, 0.7%
sodium chloride, 0.005% calcium chloride, and 0.05%
sodium phosphate dibasic. The remainder of the soaking
solution comprised deionized and distilled water with
the pH adjusted to 7.2 with 1 N hydrochloric acid.
After soAkin~ for 18 hours each lens was rubbed and
rinsed lightly with isotonic saline to remove non-bound
protein solution.
Each of the cyclodextrin compositions were pre-
pared by mixing 1.0% of the selected cyclodextrin in anaqueous isotonic phosphate buffered saline containing
0.3% hydrated sodium phosphate dibasic, and 0.9% sodium
chloride. The remainder of the solution was deionized,
distilled water with the pH adjusted to 7.2 with 1 N
hydrochloric acid.
Example 1
Ten protein deposited lenses were allowed to soak
in 10 ml per lens of the cyclodextrin composition.
After 4 hours, the lenses were removed from the test
solution and so~ke~ in the isotonic phosphate buffered
W~92/07056 rCT/US91/07742
7 2 ~ ~3 ~
saline for about 10 minutes to remove excess solution.
The lenses were analyzed to determine the total
remaining protein bound to the lens after cleAning
using a standard ninhydrin assay for the colorimetric
determination of protein adapted for use with
hydrophilic contact lenses.
The ninhydrin reagent was prepared according to
the method described by Shibata and ~atoba in Modified
Colorimetric Ninhydrin Methods for Peptidase Assay,
Analytical Biochemistry 1981: 118:173-184. A citrate-
acetate buffer was prepared with 0.5 moles acetic acid
and 0.1 moles citric acid adjusted to pH 5.0 with 10 N
sodium hydroxide. The ninhydrin reagent was prepared
by dissolving 20 mg of stannous chloride and 200 mg of
ninhydrin in 10 ml of methyl cellosolve (ethylene gly-
col, monomethyl ether), then adding 10 ml of the cit-
rateacetate buffer.
The protein bound to the lenses was hydrolyzed to
their amino acid c _~ents by heating the lenses in 1
ml of 2.5 N NaCl for 2 hours at 100-C. Aliquots of
hydrolyzed solution camples (0.015 ml) were placed into
disposable polys~ylene culture tubes. The samples were
diluted with 2.5 N sodium hydroxide prior to perfGl i ng
the analysis. To neutralize the sodium hydroxide,
glacial acetic acid (0.050 ml) was added to each of the
culture tubes and the tubes were vortexed. Ninhydrin
reagent (0.40 ml) was added to each tube, followed by
vort~Yin~.
The poly~Lyl~ne tubes were capped and heated in a
water bath at 90-C for 20 minutes, during which time
color development occurred. After 20 minutes, samples
were transferred to an ice bath and diluted with 1.0 ml
of 50~ aqueous 2-propanol.
W092/07056 PCT/US91/07742
-12- 2Q72~0~
The absorbance of each sample was recorded at
570 nm on a Spectophotometer. Standard protein
calibration curves (absorbance vs protein
concentration) were prepared in the o.0 - 15.0 ug range
with a known amount of a lysozyme standard ~ubjected to
the same analysis procedure. A protein standard was
prepared using lysozyme (Grade I, from chicken egg
white, 3X crystallized, dialyzed and lyophilized; Sigma
Chemical Company). A known amount of lysozyme was
added to a culture tube and dissolved in 1.0 ml of 2.5
N sodium hydroxide. The culture tubes containing the
lenses and the lysozyme standard were tightly capped
and placed into a heating block preheated to lOO C.
Samples were hydrolyzed for two hours, removed from the
heating block and allowed to cool to room temperature.
Protein concentrations were determined by
c ,-rison of absorbance readings with the lysozyme
standard curve and calculating the concentration of
protein per lens based on appropriate dilution factors.
The results are shown in Table 1.
Exam~le 2
Protein deposited lenses were placed into a Bausch
& Lomb White Lens Carrying Case containing 3 ml of the
cyclodextrin composition. The lens cases were cycled
through one disinfecting cycle in a Bausch & Lomb DUIV
Thermal Disinfecting Unit. The typical heat profile of
this unit raises the solution temperature to ~reater
than 60 C for about 20 minutes, and greater than 70-C
for about 10 minutes. This heat profile is commonly
accepted as that necessAry to disinfect contact lenses.
After the cycle was complete, each lens was soA~ed in
an isotonic phosphate buffered saline solution to re-
~ove any residual cyclodextrin composition adhering to
W092/070~ PCT~US91/07742
-13- 2~72~1
the lenses prior to total protein analysis by a similar
procedure as described in Example 1.
Control protein levels were established for the
lenses by using 10 lenses which have had protein de-
posited on them using the procedure described above and
which have not been previously cleaned. The percent
cleaning was dete ; ne~ by subtracting the tested val-
ues from the control values and dividing ~y the control
values. This number is multiplied by 100 to convert to
percent. The results are shown in Table 1.
As shown in Table l, the cyclodextrin composition
exhibited cle~ni ng activity under both ambient and
elevated temperatures.
Thus, it should be apparent to those skilled in
the art that the present invention is not limited by
the examples set forth above and that the use of spe-
cific compositions can be determined from the specifi-
cation without departing from the invention as herein
disclosed and described. It should be understood that
the scope of the present invention includes all
modifications and variations that fall within the scope
of the attached claims.
W O 92/07056 P(~r/US91/07742
-14- ~72~
TaLBL~ 1
l~mbient ~ntl T~e ~l C1eA~ng of Contaot T-sn~es
~x~mple 1 ~Ambient)
~verage Protei~ 8t~dard
Remaining o~ Deviation Perce~t
C-- -u~d ~ ~ens (micro gram~) ~N=10)Cle~;ng
Control 1115.1 +/-73.5
Alpha-Cyclodextrin891. 5 +/-111. 220 . 0
Gamma-Cyclodextrin 934 .8 +/- 73.1 16.1
Beta-Cyclodextrin993.0 +/-69.110.9
Methyl-Beta-
Cyclodextrin1042.8 +/-46.0 6.5
Hydroxypropyl -Beta-
Cyclodextrin MS=0 . 6 1079.4+/- 105.2 3.2
Hydroxyethyl -Beta -
Cyclodextrin MS=0.6 1127.6 +/- 120.7 -1.0
~x~mple 2 lThermal)
Average Protein 8tandard
~em~n~ng on Dev~at~on Percent
Compound ~ Len~ lmicro gram~) (N=10)Cle~n~ng
Control 1115.1 +/- 73.5
Alpha-Cyclodextrin939.0 +/- 106.915.8
Gamma-Cyclodextrin991.1 +/- 76.411.1
Beta-Cyclodextrin925.7 +/- 71.217.0
Methyl-Beta-
Cyclodextrin 860.1 +/- 65.327.9
Hydroxypropyl-Beta-
Cyclodextrin MS=0.6 826.5 +/- 15.8 25.9
Hydroxyethyl -Beta-
Cyclodextrin MS=0.6 908.5 +/- 24.6 18.5
